(Q46279559)

21 December 2017

title

Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation (English)

1 reference

21 December 2017

author

Thad A. Harroun

series ordinal

1

1 reference

21 December 2017

author name string

Bradshaw JP

series ordinal

2

1 reference

21 December 2017

Ashley RH

series ordinal

3

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

21 December 2017

published in

FEBS Letters

1 reference

21 December 2017

volume

507

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

200-204

1 reference

21 December 2017

Configurations of Polypeptide Chains With Favored Orientations Around Single Bonds: Two New Pleated Sheets

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Histochemical observations on amyloid with reference to polarization microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

An atomic model for the pleated beta-sheet structure of abeta amyloid protofilaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Amyloid fibril toxicity in Alzheimer's disease and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Bax, but not Bcl-xL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Phosphatydylglycerol promotes bilayer insertion of salmon calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Direct conversion of an oligopeptide from a beta-sheet to an alpha-helix: a model for amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

The toxicity in vitro of beta-amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

The role of prion peptide structure and aggregation in toxicity and membrane binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Polymorphic Fibrillar Assembly of Human Amylin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Pore formation by the cytotoxic islet amyloid peptide amylin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Interaction of proteins with lipid monolayers at the air-solution interface studied by reflection spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

A Langmuir film balance study of the interactions of ionic and polar solutes with glycolipid monolayers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

Congo red protects against toxicity of beta-amyloid peptides on rat hippocampal neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902972-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(01)02972-6

1 reference

21 December 2017

1 reference

21 December 2017